BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 11431713)

  • 1. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
    Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
    Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.
    Sika-Paotonu D; Bethwaite PB; McCredie MR; William Jordan T; Delahunt B
    Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Papillary renal cell carcinoma: clinico-pathologic studies of 33 cases].
    Liu LN; Chen GY; Wang P; Zhang CH; Huang SF
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):102-5. PubMed ID: 15946550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features.
    Kunju LP; Wojno K; Wolf JS; Cheng L; Shah RB
    Hum Pathol; 2008 Jan; 39(1):96-101. PubMed ID: 17949780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
    Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
    Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes.
    Leroy X; Zini L; Leteurtre E; Zerimech F; Porchet N; Aubert JP; Gosselin B; Copin MC
    Mod Pathol; 2002 Nov; 15(11):1126-30. PubMed ID: 12429790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
    Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
    Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.
    Delahunt B; Eble JN
    Mod Pathol; 1997 Jun; 10(6):537-44. PubMed ID: 9195569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pax-2 expression in adult renal tumors.
    Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
    Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors.
    Gunawan B; von Heydebreck A; Fritsch T; Huber W; Ringert RH; Jakse G; Füzesi L
    Cancer Res; 2003 Oct; 63(19):6200-5. PubMed ID: 14559804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.
    Moch H; Gasser T; Amin MB; Torhorst J; Sauter G; Mihatsch MJ
    Cancer; 2000 Aug; 89(3):604-14. PubMed ID: 10931460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
    Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
    Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
    Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.